UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism-Reference-Cited by-同舟云学术

UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism

Published:2013 Issue: Volume:4 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Bang Anne Kirstine,Jørgensen Niels,Rajpert-De Meyts Ewa,Juul Anders

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

2. Long‐term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study;Andrology;2021-11-23

3. Determination of anabolic steroids in dried blood using microsampling and gas chromatography-tandem mass spectrometry: Application to a testosterone gel administration study;Journal of Chromatography A;2020-09

4. Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism;Andrology;2017-11-16

5. Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido®or Reandron®) in men with congenital hypogonadotrophic hypogonadism;Clinical Endocrinology;2016-02-10